GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Book Value per Share

EQL Pharma AB (FRA:7JK) Book Value per Share : €0.54 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Book Value per Share?

EQL Pharma AB's book value per share for the quarter that ended in Mar. 2024 was €0.54.

During the past 12 months, EQL Pharma AB's average Book Value Per Share Growth Rate was 14.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 24.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 28.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of EQL Pharma AB was 124.50% per year. The lowest was 7.50% per year. And the median was 24.10% per year.

EQL Pharma AB's current price is €4.19. Its book value per share for the quarter that ended in Mar. 2024 was €0.54. Hence, today's PB Ratio of EQL Pharma AB is 7.76.

During the past 12 years, the highest P/B Ratio of EQL Pharma AB was 47.87. The lowest was 2.65. And the median was 5.99.


EQL Pharma AB Book Value per Share Historical Data

The historical data trend for EQL Pharma AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Book Value per Share Chart

EQL Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.31 0.40 0.48 0.54

EQL Pharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.48 0.48 0.53 0.54

Competitive Comparison of EQL Pharma AB's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's PB Ratio falls into.



EQL Pharma AB Book Value per Share Calculation

EQL Pharma AB's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(15.71-0.00)/29.06
=0.54

EQL Pharma AB's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(15.71-0.00)/29.06
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


EQL Pharma AB  (FRA:7JK) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


EQL Pharma AB Book Value per Share Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (FRA:7JK) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines